Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 4 boards, counting each seat separately. Longest: Adaptive Biotechnologies Corporation, 3 years.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Abbott Laboratories | Shares withheld for tax | −52,507 | $103.99 | $5,460,203 |
| May 20, 2026 | Align Technology Inc. | Option exercise | +1,745 | — | — |
| Apr 24, 2026 | Abbott Laboratories | Grant or award | +2,286 | — | — |
| May 21, 2025 | Align Technology Inc. | Option exercise | +1,148 | — | — |
| May 22, 2024 | Align Technology Inc. | Option exercise | +660 | — | — |
| Mar 6, 2023 | Adaptive Biotechnologies Corporation | Grant or award | +14,775 | — | — |
Questions about Kevin T. Conroy
What boards is Kevin T. Conroy on?
Kevin T. Conroy sits on the boards of Abbott Laboratories, Adaptive Biotechnologies Corporation, Align Technology Inc. and American Exceptionalism Acquisition Corp. A.
How long has Kevin T. Conroy served on boards?
Our records show at least 8 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.